Aerosol Drug Delivery
Total Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
900
NCT00415909
TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2006
Completion: May 31, 2013
NCT01477801
Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels
Phase: Phase 2/3
Start: Nov 30, 2011
Completion: Sep 30, 2012
NCT03122730
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB
Role: Lead Sponsor
Start: Aug 23, 2017
Completion: May 30, 2019
NCT03969992
A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
Start: Mar 4, 2020
Completion: Aug 5, 2024
NCT04452669
VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
Start: Sep 15, 2020
Completion: Jun 29, 2021
NCT04702087
Omega 3, Leucine, Probiotic Lactobacillus Paracasei PS23 on Muscle Mass in Sarcopenic Subjects
Phase: N/A
Start: Jan 22, 2021
Completion: Dec 31, 2022
NCT06776783
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Phase: Phase 3
Start: Sep 24, 2025
Completion: May 31, 2029
Loading map...